Oral vasoactive medication in intermittent claudication: utile or futile? T. L. De BackerR. H. Vander SticheleM. G. Bogaert REVIEW ARTICLE Pages: 199 - 206
A randomized controlled assessment of the systemic activity of budesonide when given once or twice daily via Turbuhaler L. ThorssonA. Källén CLINICAL TRIALS Pages: 207 - 210
Psychomotor effects of zaleplon and thioridazine coadministration J. HettaJ.-E. BromanS. M. Troy PHARMACODYNAMICS Pages: 211 - 217
Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain F. MoolenaarW. J. MeijlerJ. H. Proost PHARMACOKINETICS AND DISPOSITION Pages: 219 - 223
Effect of fluconazole on plasma fluvastatin and pravastatin concentrations T. KantolaJ. T. BackmanP. J. Neuvonen PHARMACOKINETICS AND DISPOSITION Pages: 225 - 229
Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome W. M. O'NeilB. M. GilfixI. W. Wainer PHARMACOKINETICS AND DISPOSITION Pages: 231 - 240
Intravesical administration of 5-aminolevulinic acid (5-ALA) Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX G. PopkenW. Schultze-SeemannU. Wetterauer PHARMACOKINETICS AND DISPOSITION Pages: 241 - 246
Pharmacokinetics and organ distribution of intravenous and oral methylene blue C. PeterD. HongwanB. H. Lauterburg PHARMACOKINETICS AND DISPOSITION Pages: 247 - 250
High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfotiamine T. FrankR. BitschG. Stein PHARMACOKINETICS AND DISPOSITION Pages: 251 - 257
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole L. L. von MoltkeA. L. B. DurolD. J. Greenblatt PHARMACOKINETICS AND DISPOSITION Pages: 259 - 261
Hydroquinine pharmacokinetics after oral administration in adult patients with muscle cramps H. J. M. van KanP. H. P. JansenA. L. M. Verbeek PHARMACOKINETICS AND DISPOSITION Pages: 263 - 267
Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions U. BergmanM. AndersenN. Montanaro PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 269 - 272
Drug–drug interactions of new active substances: mibefradil example M. SiepmannW. Kirch LETTER TO THE EDITORS Pages: 273 - 273